CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 248 filers reported holding CANTEL MEDICAL CORP in Q2 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,081,000 | +4.2% | 38,590 | +2.9% | 0.03% | -3.6% |
| Q4 2020 | $2,956,000 | +75.2% | 37,490 | -2.3% | 0.03% | +47.4% |
| Q3 2020 | $1,687,000 | +0.1% | 38,390 | +0.7% | 0.02% | 0.0% |
| Q2 2020 | $1,686,000 | +23.2% | 38,110 | 0.0% | 0.02% | +18.8% |
| Q1 2020 | $1,368,000 | -49.4% | 38,110 | 0.0% | 0.02% | -27.3% |
| Q4 2019 | $2,702,000 | -8.1% | 38,110 | -3.1% | 0.02% | -8.3% |
| Q3 2019 | $2,940,000 | -7.3% | 39,310 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $3,170,000 | +17.6% | 39,310 | -2.5% | 0.02% | +14.3% |
| Q1 2019 | $2,696,000 | -11.3% | 40,310 | -1.2% | 0.02% | -19.2% |
| Q4 2018 | $3,038,000 | -19.7% | 40,810 | -0.7% | 0.03% | 0.0% |
| Q3 2018 | $3,785,000 | -15.3% | 41,110 | -9.5% | 0.03% | -13.3% |
| Q2 2018 | $4,467,000 | -29.4% | 45,410 | -20.1% | 0.03% | -30.2% |
| Q1 2018 | $6,329,000 | -11.7% | 56,810 | -18.5% | 0.04% | -4.4% |
| Q4 2017 | $7,167,000 | -7.9% | 69,667 | -15.7% | 0.04% | -6.2% |
| Q3 2017 | $7,781,000 | +4.4% | 82,630 | -13.6% | 0.05% | 0.0% |
| Q2 2017 | $7,451,000 | -9.5% | 95,630 | -6.9% | 0.05% | -7.7% |
| Q1 2017 | $8,229,000 | -13.3% | 102,730 | -14.8% | 0.05% | -13.3% |
| Q4 2016 | $9,492,000 | -23.9% | 120,530 | -24.7% | 0.06% | -25.9% |
| Q3 2016 | $12,476,000 | +0.2% | 159,990 | -11.7% | 0.08% | -1.2% |
| Q2 2016 | $12,457,000 | -14.0% | 181,243 | -10.7% | 0.08% | -13.7% |
| Q1 2016 | $14,478,000 | -4.6% | 202,887 | -16.9% | 0.10% | -4.0% |
| Q4 2015 | $15,180,000 | +0.9% | 244,287 | -7.9% | 0.10% | 0.0% |
| Q3 2015 | $15,042,000 | -9.4% | 265,288 | -14.2% | 0.10% | +10.0% |
| Q2 2015 | $16,602,000 | +0.0% | 309,338 | -11.5% | 0.09% | +3.4% |
| Q1 2015 | $16,598,000 | +3.4% | 349,438 | -5.8% | 0.09% | +3.6% |
| Q4 2014 | $16,051,000 | +19.8% | 371,038 | -4.8% | 0.08% | +16.7% |
| Q3 2014 | $13,400,000 | -7.6% | 389,748 | -1.6% | 0.07% | -5.3% |
| Q2 2014 | $14,501,000 | +3.5% | 395,973 | -4.7% | 0.08% | 0.0% |
| Q1 2014 | $14,011,000 | -2.6% | 415,509 | -2.0% | 0.08% | -1.3% |
| Q4 2013 | $14,378,000 | +5.4% | 424,009 | -1.0% | 0.08% | -3.8% |
| Q3 2013 | $13,643,000 | +42.9% | 428,359 | +52.0% | 0.08% | +33.3% |
| Q2 2013 | $9,548,000 | – | 281,891 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
| Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
| Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
| Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
| Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
| Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
| EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
| FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |